Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 70.02B | 69.23B | 65.45B | 58.76B | 52.15B | 49.91B |
Gross Profit | 10.75B | 10.68B | 10.04B | 10.57B | 9.63B | 5.66B |
EBITDA | 9.86B | 9.18B | 7.50B | 8.07B | 7.65B | 2.07B |
Net Income | 4.93B | 4.23B | 3.79B | 4.25B | 4.21B | -1.17B |
Balance Sheet | ||||||
Total Assets | 129.04B | 129.21B | 118.87B | 115.94B | 107.05B | 110.09B |
Cash, Cash Equivalents and Short-Term Investments | 12.70B | 19.18B | 18.83B | 18.25B | 16.43B | 16.52B |
Total Debt | 10.63B | 11.28B | 13.59B | 10.98B | 13.46B | 15.62B |
Total Liabilities | 105.89B | 109.52B | 101.14B | 102.96B | 97.56B | 103.64B |
Stockholders Equity | 23.06B | 19.61B | 17.70B | 12.95B | 9.47B | 6.45B |
Cash Flow | ||||||
Free Cash Flow | 2.48B | 3.73B | 3.20B | 3.82B | 2.71B | -7.18B |
Operating Cash Flow | 6.17B | 7.40B | 6.25B | 6.29B | 4.64B | -5.42B |
Investing Cash Flow | -5.56B | -6.65B | -4.13B | -3.11B | -2.72B | 4.13B |
Financing Cash Flow | -2.73B | -2.57B | -1.28B | -2.12B | -2.18B | 6.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $84.40B | 21.00 | 17.91% | 1.86% | 11.85% | 16.12% | |
76 Outperform | $209.25B | 34.58 | 10.13% | 1.64% | 15.44% | 164.00% | |
71 Outperform | $84.47B | 21.69 | 26.50% | 1.45% | -0.65% | 77.20% | |
70 Outperform | $161.68B | 30.02 | 23.80% | 1.74% | 5.72% | 59.43% | |
64 Neutral | $99.98B | 24.11 | 73.06% | 3.05% | 1.09% | -35.50% | |
58 Neutral | HK$13.20B | 4.34 | -2.94% | 5.79% | 3.03% | -49.30% | |
56 Neutral | $170.03B | ― | -162.23% | ― | 2.41% | -193.57% |